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ApoptosisEnteroviral infections are associated with type I diabetes. The mechanisms by which viruses or viral products
such as double-stranded RNA (dsRNA) affect pancreatic beta cell function and survival remain unclear. We
have shown that extracellular dsRNA induces beta cell death via Toll-like receptor-3 (TLR3) signaling
whereas cytosolic dsRNA triggers the production of type I interferons and apoptosis via a TLR3-independent
process. We presently examined expression of the intracellular viral RNA sensors, the RNA helicases RIG-I
and MDA5, and documented the functionality of RIG-I in pancreatic beta cells.
FACS-puriﬁed rat beta cells and islet cells from wild-type or TLR3−/−mice were cultured with or without the
RIG-I-speciﬁc ligand 5′-triphosphate single-stranded RNA (5′triP-ssRNA), the synthetic dsRNA polyI:C (PIC)
or 5′OH-ssRNA (negative control); the RNA compounds were added in the medium or transfected in the cells
using lipofectamine. RIG-I and MDA5 expression were determined by real-time RT-PCR. NF-κB and IFN-β
promoter activation were studied in the presence or absence of a dominant-negative form of RIG-I (DN-RIG-
I). Both extracellular (PICex) and intracellular (PICin) PIC increased expression of RIG-I and MDA5 in
pancreatic beta cells. TLR3 deletion abolished PICex-induced up-regulation of the helicases in beta cells but
not in dendritic cells. PICin-induced NF-κB and IFN-β promoter activation were prevented by the DN-RIG-I.
The RIG-I-speciﬁc ligand 5′triP-ssRNA induced IFN-β promoter activation and beta cell apoptosis. Our results
suggest that the RIG-I pathway is present and active in beta cells and could contribute to the induction of
insulitis by viral RNA intermediates.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Type 1 diabetes (T1D) is a severe chronic disease resulting from a
progressive and selective loss of functional insulin-producing beta cells
through an autoimmune-mediated process [1]. The incidence of T1D
shows seasonal and geographic-dependent variations. This, together
with the increasedoccurrenceof thedisease in the last decades, suggests
that both genetic and environmental factors contribute for its
pathogenesis. Various putative environmental agents have been
implicated in the etiology of T1D, and there is now increased evidence
suggesting that viral infections may play a role in the process [2,3]. This
hypothesis is supported by studies showing the presence of enterovirus
or enteroviral RNA in the serum and in pancreatic islets of newly
diagnosed T1D children and adults [4–7]. Moreover, high levels of
antibodies against enteroviruses were detected [8,9] and found
associated with the presence of beta cell autoantibodies at early onsetand Nutrition, Université Libre
Belgium. Tel.: +32 2 555 6307;
ll rights reserved.of the disease [10,11]. The molecular mechanisms involved in virus-
inducedbeta cell damage andapoptosis remain, however, to be clariﬁed.
Recognition of viral pathogen-associated molecular patterns
(PAMPs) by the host cells is essential to initiate innate immune
responses and overcome infections [12]. Cells possess a variety of
innate immune pattern recognition receptors to detect viral PAMPs.
These include the Toll-like receptors (TLRs), the double-stranded RNA
(dsRNA)-dependent protein kinase R (PKR) and the newly identiﬁed
retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) which
include RIG-I, MDA5 and Lgp-2. TLR3 and RLRs detect viruses by
binding dsRNA [13–15], a common intermediary product of the viral
life cycle [16]. In the course of viral infection, dsRNA accumulates both
in the cytosol of infected cells and in the extracellular compartment
and activates antiviral responses, contributing to trigger the subse-
quent adaptive immune response [17,18]. TLR3 detects mostly
extracellular dsRNA phagocytosed in endosomes, while RLRs sense
cytosolic viral dsRNA [14,19].
Poly (I:C) (PIC), a dsRNA synthetic analogue, mimics the effects of
viral dsRNA in vivo and in vitro and triggers cellular dysfunction and
apoptosis in pancreatic beta cells [20–23]. Exposure of puriﬁed rat
beta cells to extracellular PIC or infection of human pancreatic islets
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RIG-I mRNAs expression [23–25]. Of note, PIC is recognized by both
TLR3 and RLRs [14,15,26,27]. In a previous study, we demonstrated
that extracellular PIC-mediated beta cell apoptosis and expression of
pro-inﬂammatory genes is abolished in islet cells from TLR3 knockout
(TLR3−/−) mice, indicating that the TLR3 pathway is required for
extracellular dsRNA-mediated beta cell death and inﬂammatory
signaling [28]. The TLR3−/− islet cells are, however, only partially
protected against internal dsRNA-triggered modiﬁcations in mRNA
expression and subsequent apoptosis, suggesting a role for other
signaling pathways that remain to be determined [28].
RIG-I and melanoma differentiation-associated gene 5 (MDA5) are
homologous cytosolic proteins members of the RLRs family [29]. They
contain a C-terminal helicase domain that binds dsRNA and two NH2-
terminal caspase activation and recruitment domains (CARDs) acting as
signaling domains and implicated in homotypic interactions related to
inﬂammatory or cell death pathways [30]. Besides recognizing dsRNA,
RIG-I also recognizes uncapped 5′-triphosphate single-stranded RNA
(5′triP-ssRNA), awell-deﬁnedmolecular structure of viral nucleic acids
[31,32]. The binding of dsRNA or 5′triP-ssRNA to RIG-I or MDA5
promotes their interaction with the adaptor molecule VISA [33]. VISA
further transmits downstreamsignals that result in the activation of the
transcription factors NF-κB and IRF-3 and the subsequent synthesis and
secretion of type I interferons (IFNs) [34,35].
We have recently shown that intracellular PIC activates IRF-3 and
NF-κB in pancreatic beta cells, inducing a massive production of type I
IFNswhich contributes to cytosolic dsRNA-induced apoptosis in a TLR3-
independent process [28]. To clarify the nature of these TLR3-
independent mechanisms, which may play a relevant role for dsRNA-
induced beta cell death and insulitis, we presently examined the
expression of the RNA helicases RIG-I andMDA5 in puriﬁed primary rat
beta cells and in islet cells isolated fromTLR3−/−orwild-typemice. The
functionality of RIG-I was then evaluated using a RIG-I-speciﬁc ligand
and a dominant-negative form of the protein. The results obtained
suggest that the RIG-I pathway is present and active in pancreatic beta
cells and might contribute to the deleterious effects of viral RNA
intermediates on beta cell function and to the induction of insulitis.
2. Materials and methods
2.1. Animals
Adult male Wistar rats (Charles River Laboratories, Brussels,
Belgium), C57/BL6 (Harlan CBP, Zeist, The Netherlands) and TLR3
knockout (TLR3−/−) mice [13] were housed and used according to
the guidelines of the Belgian Regulations for Animal Care. TLR3−/−
mice were kept under speciﬁc pathogen-free (SPF) conditions at theTable 1
Primer sequences for RIG-I, MDA5 and GAPDH and their respective fragment length.
Gene P
RIG-I qPCR S
A
Standard S
A
MDA5 qPCR S
A
Standard S
A
GAPDH (rat) qPCR S
A
Standard S
A
GAPDH (mouse) qPCR S
A
Standard S
AKatholieke Universiteit van Leuven (KUL). All experiments were
conducted with the approval of the Animal Ethics Committees of the
Université Libre de Bruxelles and KUL.
2.2. Cell culture
Pancreatic islets were isolated, digested, hand-picked under a
stereomicroscope and dissociated into single cells in the presence of
dispase (0.5 mg/ml). Beta cells were puriﬁed by autoﬂuorescence-
activated cell sorting (FACS, FACStar; Becton-Dickinson, Sunnyvale,
CA) [23]. Puriﬁed beta cells (N90% pure) were then cultured in HAM's
F-10 medium as previously described [23].
Mouse spleen cells were digested with collagenase P (3.5 U/ml),
further dissociated in calcium-free medium and separated into low-
and high-density fraction on a Nycodenz gradient (Nycomed). Low-
density cells were cultured for 2 h in RPMI 1640 containing 5% heat-
inactivated fetal bovine serum (FBS); non-adherent cells were then
eliminated by vigorous pipetting and adherent cells were cultured
overnight at 37 °C. After overnight culture, non-adherent cells
contained 87±2% of CD11c-positive dendritic cells (n=7) as
assessed by CD11c staining (data not shown).
2.3. Real-time RT-PCR
FACS-puriﬁed rat beta cells, mouse dispersed islet cells, CD11c or
INS-1E cells were cultured in Falcon 24-well plates (105 cells per
well); for beta cells and dispersed islet cells culture, the plates were
pre-coated with poly-L-lysine. Cells were maintained in control
condition or were exposed to either external dsRNA (tested in the
form of polyinosinic–polycytidilic acid; PICex; 100 μg/ml; Sigma) or
to internal dsRNA (PICin). Introduction of foreign dsRNA into the cells
was achieved by treating them for 4 h with a mixture of lipofectamine
and PIC (1 μg/ml for rat beta cells and 10 μg/ml for mouse dispersed
islet cells). As control condition for the internal PIC treatment, cells
were treated with lipofectamine alone (LF). Cells were harvested 2, 6
or 24 h after treatment, andmRNA (poly(A)+RNA)was extracted and
reverse transcribed as previously described [36]. Real-time quantita-
tive PCR for RIG-I, MDA5 and GAPDH was done using SYBR Green
ﬂuorescence on a Roche Lightcycler instrument in a 20-μl reaction
containing 3 mmol/l MgCl2, 0.5 μmol/l forward and reverse primers,
2 μl FastStart SYBR Green mix (Roche) and 2 μl template cDNA. The
primer sequences and their respective fragment lengths are described
in Table 1 (qPCR). The method used for quantiﬁcation was the
standard curve approach [37]. To obtain the speciﬁc standard curves,
the primers sequence and their respective PCR fragment sizes are
described in Table 1 (standard). The target cDNAs present in each
sample were corrected for their respective GAPDH values. Expressionrimer sequence Size (bp)
ense 5′-AAAGCCAGAGACCAAGACCA-3′ 200
ntisense 5′-TATCTCCGCTGGCTCTGAAT-3′
ense 5′-CACAAAGCGTGCTCAGTGTT-3′ 802
ntisense 5′-GTATGCGGTGAACCGTCTTT-3′
ense 5′-TGTCTTGGQCQCTTGCTTCG-3′ 121
ntisense 5′-TGCTGAGAAGGATTGTGCAG-3′
ense 5′-TGACGAGTGTCTCCACTTGC-3′ 612
ntisense 5′-TCCATTTGGTAAGGCCTGAG-3′
ense 5′-AGTTCAACGGCACAGTCAAG-3′ 118
ntisense 5′-TACTCAGCACCAGCATCACC-3′
ense 5′-TCCCTCAAGATTGTCAGCAAA-3′ 308
ntisense 5′-AATGTATCCGTTGTGGATCT-3′
ense 5′-AACTTTGGCATTGTGGAAGG-3′ 138
ntisense 5′-GGATGCAGGGATGATGTTCT-3′
ense 5′-TAACATCAAATGGGGTGAGG-3′ 719
ntisense 5′-TGTTGCTGTAGCCGTATTCA-3′
Fig. 1. Expression of RIG-I and MDA5 is regulated by PICin and PICex in rat beta cells.
Puriﬁed rat beta cells were cultured in the absence (Ctrl or LF) or presence of PICex
(100 μg/ml) or PICin (1 μg/ml) for 2–24 h. RIG-I (A) and MDA5 (B) mRNA expression
were analyzed by real-time RT-PCR and the data were normalized for the
housekeeping gene GAPDH. The results are means±SEM of four to six experiments.
⁎pb0.05; ⁎⁎pb 0.01; and ⁎⁎⁎pb 0.005 vs. respective control; Student's paired t-test.
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[22], aﬁnding conﬁrmed in the present experiments (data not shown).
2.4. Assessment of cell viability
Rat beta cells (104 cells per well) were cultured in Falcon 96-
well microtiter plates pre-coated with poly-L-lysine. ssRNA (polyC;
1 μg/ml; Sigma), dsRNA (polyI:C; 1 μg/ml; Sigma), in vitro-
transcribed uncapped 5′-triphospate RNA, namely 5′triP-ssRNA
(5′-pppGGGGCUGACCCUGAAGUUCAUCUU-3′; 1.33 μg/ml; prepared
as described [32]) or a chemically synthesized 5′hydroxyl-ssRNA used
as negative control (5′-OH-GGGGCUGACCCUGAAGUUCAUCUU-3′;
1.33 μg/ml; Eurogentec, Belgium) were introduced into the cells by a
4-h treatment with amixture containing lipofectamine and each of the
compounds. Cells treated with lipofectamine alone (LF) were used as
control. Dose–response studies were performed to select the most
adequate intra- and extracellular dsRNA concentrations for the present
experiments (data not shown). The transfected cells were then
maintained in culture for up to 5 days. The percentage of viable,
apoptotic or necrotic cells was assessed by incubation for 15 min with
propidium iodide (PI, 10 μg/ml) andHoechst (HO) 342 (10 μg/ml) [38].
This ﬂuorescence assay for single cells is quantitative and has been
validated by comparison against electron microscopy observations
[39], determination of DNA strand breaks [40] and caspase-3 activation
[41,42]. The method has been successfully used to evaluate apoptosis/
necrosis in rat [38,39], mouse [43,44] and human [45] beta cells.
Counting of viable, apoptotic and necrotic cells was done by two
independent observers, with one of them unaware of the tested
conditions. At least 500 cells were counted per experimental condition,
and the agreement between the observers was always N90%.
2.5. Reporter gene assay
Puriﬁed beta cells were transfected using lipofectamine with
plasmid constructs containing the ﬁreﬂy luciferase gene under the
control of either multiples copies of the NF-κB consensus sequence
(BD Biosciences Clontech) or the mouse IFN-β promoter [23,46]; a
pRL-CMV plasmid was co-transfected as internal control for trans-
fection efﬁciency. In some experiments, cells were transfected with
the plasmids described above and with an expression plasmid en-
coding for a dominant-negative form of RIG-I [14] or its empty vector
pFLAG. After 24 h, the cells were transfected either with dsRNA (PICin;
1 μg/ml), ssRNA (1 μg/ml; used as negative control), 5′triP-ssRNA
(1.33 μg/ml) or 5′OH-ssRNA (1.33 μg/ml) in the presence of lipo-
fectamine (see above); cells treated with lipofectamine alone (LF)
were used as controls. Luciferase activities were assayed 16 h later
with the Dual Luciferase Reporter Assay System (Promega, Madison,
WI) [23]. Test values were corrected for the luciferase activity value of
the internal control plasmid, pRL-CMV.
2.6. Statistical analysis
Data are presented as means±SEM of at least four independent
experiments. Statistical differences between groups were determined
either by paired Student's t-test or by ANOVA followed by t-test with
the Bonferroni correction, as indicated. A p value of less than 0.05 was
considered as statistically signiﬁcant.
3. Results
3.1. DsRNA induces RIG-I and MDA5 mRNA expression in rat pancreatic
beta cells
To examine expression of RIG-I andMDA5mRNAs, primary rat beta
cells were cultured in control condition or exposed to extracellular
dsRNA(PICex) or intracellular dsRNA (PICin) for 2, 6 or 24h. Addition ofPICex for 6 h led to a 23- and 11-fold induction of RIG-I (Fig. 1A) and
MDA5(Fig. 1B) expression, respectively. This inductionwasmaintained
up to 24 h in the case of RIG-I (Fig. 1A), while MDA5mRNA returned to
basal value at this time point (Fig. 1B).When PIC was introduced in the
cells by lipofection, the up-regulation of both RIG-I andMDA5appeared
earlier (starting already after 2 h), was more pronounced (around 50-
fold induction) and was maintained up to 24 h (Fig. 1). Of note,
expression of the adaptor molecule VISA was also detected in rat beta
cells but was not affected by PICex or PICin (data not shown).
3.2. TLR3 signaling controls RIG-I and MDA5 expression in primary
beta cells
In a previous study, we described that islet cells isolated from
TLR3−/− mice produce 4-fold less IFN-β than islet cells from wild-
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whether the TLR3 pathway regulates expression of MDA5 and/or
RIG-I in pancreatic beta cells. Dispersed islet cells were isolated from
WT or TLR3−/− mice and exposed to either PICex or PICin. As
observed in rat beta cells, exposure of WT mouse islet cells to PICex
or PICin increased both RIG-I (Fig. 2A) and MDA5 (Fig. 2B)
expression. Disruption of the TLR3 signaling pathway prevented
PICex-triggered MDA5 and RIG-I up-regulation (Fig. 2). In contrast,Fig. 2. The TLR3 pathway regulates PICex-induced RIG-I and MDA5 expression in
mouse pancreatic islet cells. Dispersed islet cells from wild-type (WT) and TLR3−/−
mice were cultured for 6 h in the absence (Ctrl or LF) or presence of PICex (100 μg/ml)
or PICin (10 μg/ml). RIG-I (A) and MDA5 (B) mRNA expression were analyzed by real-
time RT-PCR and the data were normalized for the housekeeping gene GAPDH. The
results are means±SEM of six to nine experiments. ⁎pb 0.05, ⁎⁎pb 0.01, ⁎⁎⁎pb 0.001
vs. respective control; and $pb 0.05 vs. WT; ANOVA.
Fig. 3. Expression of RIG-I and MDA5 in dendritic cells from wild-type and TLR3−/−
mice. Splenic dendritic cells (CD11c) isolated from wild-type (WT) and TLR3−/− mice
were cultured for 6 h in the absence (ctrl) or presence PICex (100 μg/ml). RIG-I and
MDA5 mRNA expression were analyzed by real-time RT-PCR and the data were
normalized for the housekeeping gene GAPDH. The results are means±SEM of six to
nine experiments. ⁎pb 0.05; ⁎⁎pb 0.01 vs. control; Student's paired t-test.intracellular dsRNA-induced up-regulation of RIG-I (Fig. 2A) and
MDA5 (Fig. 2B) was not affected by TLR3 disruption.
These results demonstrate that the TLR3 signaling pathway
controls RIG-I and MDA5 expression in response to extracellular,
but no intracellular, dsRNA in pancreatic beta cells.
To establish whether such a role for the TLR3 pathway is also
observed in other cell types, we studied expression of the helicases in
immune cells, namely splenic dendritic cells (CD11c). CD11c cells
were isolated from WT or TLR3−/− mice and exposed to PICex. As
observed in rat beta cells, exposure of WT CD11c cells to PICex
increased expression of RIG-I (Fig. 3A) and MDA5 (Fig. 3B) mRNAs. In
Fig. 5. RIG-I mediates internal dsRNA-induced NF-κB activation in rat beta cells. Puriﬁed
rat beta cells were co-transfected with an NF-κB reporter plasmid and the internal
control plasmid pRL-CMV, in the presence of either an expression plasmid encoding for
the dominant-negative form of RIG-I or pFLAG, its empty vector. 24 h later, the cells
were transfected with PIC (1 μg/ml) or ssRNA (1 μg/ml). Luciferase activities were
measured 16 h later and corrected for those obtained for the pRL-CMV plasmid in the
same sample. The results are means±SEM of 7–11 experiments, ⁎pb 0.01 vs. LF;
$pb 0.05 vs. PICin without DN-RIG-I; ANOVA.
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prevent MDA5 and RIG-I mRNA up-regulation by PICex (Fig. 3) as it
was the case for beta cells (Fig. 2).
These results show that the key role for the TLR3 pathway in
PICex-triggeredMDA5 and RIG-I expression is present in beta cells but
not in splenic dendritic cells.
3.3. RIG-I regulates IFN-β promoter and NF-κB activation in primary
beta cells
To investigate the functionality of RIG-I in pancreatic beta cells, we
examined whether PICin-induced IFN-β promoter and NF-κB activa-
tion are affected by the expression of a dominant-negative form of
RIG-I [14]. For this purpose, beta cells were co-transfected with an
IFN-β promoter or an NF-κB reporter plasmid and with a plasmid
encoding for a dominant-negative form of RIG-I (DN-RIG-I) or its
empty vector pFLAG. As shown in Fig. 4, internal dsRNA, but not
ssRNA, increased by 7-fold the IFN-β promoter activity. PICin-induced
IFN-β promoter activation was prevented by the DN-RIG-I (Fig. 4).
Likewise, PICin-induced NF-κB activation was inhibited by the DN-
RIG-I (Fig. 5). Of note, NF-κB activation by IL-1β (8.0±1.9-fold
activation; n= 4), used as positive control, was not affected by the
presence of the DN-RIG-I (9.6±2.2-fold activation; n= 4).
3.4. RIG-I stimulation by its speciﬁc ligand triggers pancreatic beta
cell apoptosis
Itwas recently described that 5′-triphosphate ssRNA(5′triP-ssRNA)
is a speciﬁc ligand for RIG-I [32]. We therefore evaluated the effect of
this compound on pancreatic beta cell viability. Introduction of 5′triP-
ssRNA in the cytosol by lipofection increased beta cell apoptosis but not
necrosis (Fig. 6). Importantly, the non-phosphorylated form of the
ssRNA fragment (5′OH-ssRNA), which is not recognized by RIG-I, did
not affect beta cell viability (Fig. 6).Fig. 4. RIG-I mediates internal dsRNA-induced IFN-β promoter activation in rat beta
cells. Puriﬁed beta cells were co-transfected with an IFN-β promoter reporter plasmid, a
pRL-CMV plasmid (used as internal control) and, as required, an expression plasmid
encoding for the dominant-negative form of RIG-I or its empty vector pFLAG. After
overnight culture, the cells were transfected with PIC (1 μg/ml) or ssRNA (1 μg/ml),
used as negative control. Luciferase activitiesweremeasured 16h later and corrected for
the values obtained with the pRL-CMV plasmid in the same sample. The results are
means±SEMof 8–14 experiments, ⁎pb 0.01 vs. LF; $pb 0.05 vs. PICinwithout DN-RIG-I;
ANOVA.We further determinedwhether intracellular 5′triP-ssRNA induces
NF-κB and IFN-β promoter activation. As shown in Fig. 7, both NF-κB
(Fig. 7A) and the IFN-β promoter (Fig. 7B) were activated by internal
5′triP-ssRNA, but not by 5′OH-ssRNA (used as negative control). Co-
transfection with the DN-RIG-I reduced 5′triP-ssRNA-induced IFN-β
promoter activation but did not affect NF-κB activation.
4. Discussion
Enteroviral infections, acting in conjunction with a predisposing
genetic background, may trigger insulitis and eventually lead to the
development of T1DM. The molecular mechanisms by which viruses
or viral RNA intermediates induce insulitis and pancreatic beta cell
death are still unclear. It has been proposed that during viral infection
the local production of cytokines and chemokines by both invading
immune cells and the pancreatic beta cells themselves may interact to
initiate and/or accelerate the transition from innate immune response
to a chronic autoimmune assault [28,47,48].Fig. 6. RIG-I stimulation by its speciﬁc ligand 5′triP-ssRNA induces beta cell apoptosis.
FACS-puriﬁed rat beta cells were transfected with PIC, 5′triP-ssRNA or 5′OH-ssRNA
(1 μg/ml); cells treated with lipofectamine alone were used as control (LF). Cell
viability was determined with the DNA-binding dyes HO 342 and PI. The results are
means±SEM of four individual experiments. ⁎pb 0.05 vs. LF; Student's paired t-test.
Fig. 7. 5′triP-ssRNA activates NF-κB and the IFN-β promoter in beta cells. Puriﬁed beta
cells were co-transfected with an NF-κB (A) or an IFN-β promoter (B) reporter plasmid
and the pRL-CMV plasmid (internal control), in the presence of either the DN-RIG-I or
pFLAG. After overnight culture, the cells were transfected with 5′triP-ssRNA or 5′OH-
ssRNA (1 μg/ml); cells treated with lipofectamine alone were used as control (LF).
Luciferase activities were corrected for those obtained for the pRL-CMV plasmid in the
same sample. The results are means±SEM of four to six experiments; ⁎pb 0.05,
⁎⁎pb 0.01 vs. LF, $pb 0.05 vs. PICin without DN-RIG-I; ANOVA.
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I IFNs through activation of the transcription factors NF-κB and IRF-3.
The subsequent transcription of IFN-stimulated genes such as pro-
inﬂammatory cytokines and chemokines will then allow prevention
of viral replication and spreading [49].
We have recently shown that pancreatic beta cells express
functional TLR3 and that this immune pattern recognition receptor
plays a key role in the modulation of beta cell gene expression and
subsequent apoptosis triggered by extracellular dsRNA [23,28]. We
further demonstrated that introduction of dsRNA in the cytosol by
lipofection induces beta cell apoptosis through activation of IRF-3 and
production of type I IFN [28]. Deletion of the TLR3 pathway, however,
neither suppressed internal dsRNA-triggered NF-κB and IRF-3
activation nor prevented beta cell apoptosis [28]. These observations
suggest that in pancreatic beta cells TLR3-independent pathway(s)
contribute to type I IFNs production, de novo gene expression and
apoptosis in response to intracellular dsRNA. The present work was
therefore initiated to clarify the nature of these TLR3-independent
mechanisms, which may play a relevant role for intracellular dsRNA-
induced beta cell death and insulitis, especially by inducing NF-κB
activation and a massive production of type I interferons, both
phenomenon having a pro-apoptotic role in pancreatic beta cells. For
this purpose, we performed the experiments in primary and pure beta
cell preparations (N90% beta cells), a model which enables us to
understand beta cell responses to viral components without the
confounding signals generated by other endocrine- and non-endocrine
islet cells.
On the other hand, use of puriﬁed beta cells isolated from their
native environment poses limitations to the extrapolation of the
ﬁndings obtained to the in vivo diabetes situation. Future studies, using
mouse models of virus-induced insulitis and diabetes, will be required
to further clarify the role for RNA helicases and TLRs in diabetes.The helicases RIG-I andMDA5were recently identiﬁed as important
cytosolic viral RNA sensors [29], triggering immune responses such as
type I IFNs production through activation of NF-κB and IRF-3 [50].
Against this background, we have presently evaluated whether beta
cells express RIG-I and MDA5 and the putative role of these cytosolic
proteins for beta cell responses to intracellular dsRNA and ssRNA. The
results obtained indicate that the dsRNA synthetic analogue PIC, when
added to the culture medium, induces a mild up-regulation of both
MDA5 and RIG-I mRNA expression, whereas introduction of PIC in the
cytosol triggers an early and more marked increase in their mRNA
levels. RIG-I and MDA-5 up-regulation depends on type I IFNs
production and we have previously shown that PICin, but not PICex,
induces amassive and sustained production of type I IFNs in pancreatic
beta cells [28].
Interestingly, we observed that expression of RIG-I and MDA5 is
modulated by the TLR3 pathway in pancreatic beta cells but not in
splenic dendritic cells suggesting a cell-type-speciﬁc role for the
innate immune pattern recognition receptor, as documented in
epithelial cells [51] and plasmacytoid dendritic cells [27].
5′-Triphosphate ssRNA is an important ligand for RIG-I [31,32], but
recent evidence indicates that RIG-I also interacts with dsRNA [52,53].
In the present study, we demonstrated that internal dsRNA-induced
NF-κB and IFN-β promoter activations are decreased by the presence
of a dominant-negative form of RIG-I, suggesting that RIG-I recognizes
dsRNA in pancreatic beta cells and thus contributes to trigger the
antiviral response. The presence of the dominant-negative form of
RIG-I reduced but did not suppress IFN-β promoter activation by
dsRNA, suggesting that other intracellular RNA sensor such as MDA-5
could also play a role in IFN-promoter activation in beta cells. The RIG-I
pathway was shown to enhance PIC-induced apoptosis in macro-
phages [54] and activation of the transcription factor NF-κB has a pro-
apoptotic role in pancreatic beta cells [55]; activation of RIG-I could
therefore contribute to internal dsRNA-induced beta cell apoptosis. In
line with this possibility, the RIG-I ligand 5′triP-ssRNA triggers beta
cell apoptosis and activates NF-κB and the IFN-β promoter. The role for
the RNA helicases RIG-I and MDA-5 in dsRNA-induced beta cell death
requires additional investigation, since a decrease (N85%) in RIG-I or
MDA-5 mRNA expression mediated by speciﬁc siRNAs failed to
prevent dsRNA-induced beta cell death [56; ColliM.L. et al.,manuscript
in preparation].
A dominant-negative formof RIG-I partially prevented activation of
the IFN-β promoter but did not affect activation of the transcription
factor NF-κB by 5′triP-ssRNA. This last observationmight be explained
by the recent demonstration that PKR, awell-knownactivator ofNF-κB
in response to intracellular dsRNA, is also activated by 5′triP RNA,
independently of RIG-I [57].
The cell-type-speciﬁc responses to viral infections may reﬂect the
different capacity of infected cells to recognize virally produced
molecules such as dsRNA or uncapped 5′-triphosphate ssRNA, leading
to a preferential induction of TLR3-, RIG-I- or MDA5-dependent re-
sponses [58–61]. Expression of several antiviral receptors and path-
ways was up to now considered to be restricted to epithelial cells [62],
in which stimulation of these receptors activate antiviral but not pro-
inﬂammatory responses [63]. The present and previous data from our
group [23,28] and others [25] demonstrate that pancreatic beta cells
are remarkably well equipped to respond to viral RNA intermediates,
expressing several functional innate immune pattern recognition
receptors involved in the production of cytokines, chemokines and
type I IFNs [64]. Of interest, Chehadeh et al. [65] demonstrated that
infection of human islets by coxsackievirus leads to viral replication in
both alpha and beta islet cells while it triggers the synthesis of IFN-α
in beta cells only, suggesting that the beta cell-speciﬁc IFN-α
production may play a role in the initiation and/or the maintenance
of chronic CVB infection in human islets. High levels of type I IFNs
have been detected in the pancreas or islets of type 1 diabetic patients
[66,67] and these cytokines are implicated in the pathogenesis of
1774 M. García et al. / Biochimica et Biophysica Acta 1793 (2009) 1768–1775viral-induced type 1 diabetes [68,69]. Our results suggest that the
presence of viral compounds in the cytosol of beta cells triggers a
massive production of type I IFNs, partially through activation of
RIG-I, leading to the initiation of antiviral responses in neighboring
cells. Since TLR3 is highly expressed in pancreatic beta cells [70], the
viral dsRNA released by dying cells will also activate the TLR3
pathway in surrounding non-infected cells. Stimulation of the TLR3
pathway, acting in conjunction with the IFNs produced by both the
beta cells and the invading immune cells [23,28], may therefore
improperly initiate the apoptotic machinery in non-infected beta
cells, amplifying beta cell death and accelerating the transition from
the innate immune response to a chronic autoimmune assault in
genetically predisposed individuals.
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